Catalyst Wire Dossier Catalyst Wire Dossier

GLA-SE adjuvant

GLA-SE
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GLA-SE adjuvant, covering 2023-02-01 to 2024-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy [Phase 1]

See pricing